Harnessing the Power of Patient-Reported Outcomes in Oncology
暂无分享,去创建一个
[1] L. Minasian,et al. Use of PRO Measures to Inform Tolerability in Oncology Trials: Implications for Clinical Review, IND Safety Reporting, and Clinical Site Inspections , 2017, Clinical Cancer Research.
[2] L. Traeger,et al. The relationship between physical and psychological symptoms and health care utilization in hospitalized patients with advanced cancer , 2017, Cancer.
[3] Deborah Schrag,et al. Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] S. Kaasa,et al. The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06). , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] Gaetano Rocco,et al. Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.